| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | -0.11% | +0.70% | -0.81% | -7.02% | — |
| 14d | 4 | +75.00% | +1.80% | +2.95% | -1.14% | -5.17% | — |
| 30d | 4 | +75.00% | -0.67% | +6.05% | +2.83% | +2.83% | — |
| 60d | 4 | +75.00% | -3.35% | +3.50% | -6.84% | -9.20% | — |
| 90d | 4 | +0.00% | +26.03% | +4.25% | +21.78% | +16.00% | — |
| 180d | 4(4 pending) | — | — | — | — | — | — |
| 1y | 4(4 pending) | — | — | — | — | — | — |
| 2y | 4(4 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 14,140 | $37.70 | $533.1K | 175,106 | Jul 17, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 200 | $38.39 | $7.7K | 174,906 | Jul 17, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,833 | $37.05 | $105.0K | 189,246 | Jul 17, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 7,464 | $36.66 | $273.6K | 193,671 | Jul 16, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 1,592 | $37.44 | $59.6K | 192,079 | Jul 16, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 4,510 | $36.94 | $166.6K | 201,135 | Jul 15, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 5,545 | $36.13 | $200.3K | 205,645 | Jul 15, 2026 | Jul 20, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 8,346 | $28.96 | $241.7K | 248,266 | Apr 27, 2026 | Apr 29, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,821 | $30.50 | $238.5K | 211,190 | Apr 27, 2026 | Apr 29, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 29,255 | $29.63 | $866.8K | 219,011 | Apr 27, 2026 | Apr 29, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 3,316 | $26.61 | $88.2K | 256,612 | Apr 15, 2026 | Apr 17, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,020 | — | — | 259,928 | Feb 5, 2026 | Feb 9, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 24,455 | — | — | 24,455 | Feb 5, 2026 | Feb 9, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | SALE Chief Discovery Officer | 42,099 | $17.98 | $756.9K | 253,908 | Jan 27, 2026 | Jan 29, 2026 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 146,052 | — | — | 146,052 | Oct 27, 2025 | Oct 28, 2025 ↗ | View → |
| MPLT MAPLIGHT THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,953 | — | — | 35,953 | Oct 27, 2025 | Oct 28, 2025 ↗ | View → |